02315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 38.30
−8.81%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 38.28x
- P/E 2027E
- 23.60x
- P/E 2028E
- 15.34x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 38.32x
- PEG TTM
- —
- Price / book
- 5.38x
- Price / sales
- 7.66x
- Price / cash flow
- 31.70x
Enterprise value
- Enterprise value
- HKD 15.1B
- EV / sales
- 7.57x
- EV / EBITDA
- 21.99x
- EV / EBIT
- 29.14x
- Market cap
- HKD 15.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026